SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001682852-24-000027
Filing Date
2024-05-02
Accepted
2024-05-02 16:03:11
Documents
86
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrna-20240331.htm   iXBRL 10-Q 1125631
2 EX-31.1 exhibit3113312024.htm EX-31.1 9144
3 EX-31.2 exhibit3123312024.htm EX-31.2 9089
4 EX-32.1 exhibit3213312024.htm EX-32.1 8219
10 mrna-20240331_g1.jpg GRAPHIC 63925
11 mrna-20240331_g2.jpg GRAPHIC 640381
  Complete submission text file 0001682852-24-000027.txt   8776524

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20240331.xsd EX-101.SCH 51019
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20240331_cal.xml EX-101.CAL 110625
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20240331_def.xml EX-101.DEF 191085
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20240331_lab.xml EX-101.LAB 536146
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20240331_pre.xml EX-101.PRE 389600
89 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20240331_htm.xml XML 1283686
Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38753 | Film No.: 24908038
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)